SKI Market

Indian Indices

Nifty

24,837.00 -225.10
(-0.90%)

Sensex

81,463.09 -721.08
( -0.88%)

Bank Nifty

56,528.90 -537.15
( -0.94%)

Nifty IT

35,623.75 -512.05
( -1.42%)

Global Indices

Nasdaq

44,929.79 214.87
(0.48%)

Dow Jones

6,410.96 26.61
(0.42%)

Hang Seng

41,458.88 -367.46
(-0.88%)

Nikkei 225

9,120.31 -18.06
(-0.20%)

Forex

USD-INR

86.38 0.01
(0.01%)

EUR-INR

101.61 0.16
(0.16%)

GBP-INR

116.99 -0.03
(-0.02%)

JPY-INR

0.59 0.00
(0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Bafna Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532989

INE878I01022

35.8493127

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BAFNAPH

33.69

211.98

EPS(TTM)

Face Value()

Div & Yield %

2.66

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	152.47	115.35	85.14	71.22	42.47	43.63
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	152.47	115.35	85.14	71.22	42.47	43.63
Other Income	3.52	3.27	1.70	0.75	0.26	0.39
Stock Adjustments	4.85	2.91	1.77	-2.95	3.24	-0.81
Total Income	160.84	121.53	88.61	69.02	45.97	43.21
EXPENDITURE :
Raw Materials	91.58	65.98	41.70	33.58	23.22	27.00
Power & Fuel Cost	6.73	5.31	3.93	2.95	2.69	2.50
Employee Cost	19.03	15.87	14.65	11.98	10.25	9.01
Other Manufacturing Expenses	13.83	8.68	7.72	6.72	5.02	4.48
Selling & Administrative Expenses	13.98	5.39	6.92	2.67	3.18	3.13
Miscellaneous Expenses	1.06	1.33	2.19	0.07	23.45	9.77
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	146.20	102.55	77.11	57.97	67.80	55.89
Operating Profit	14.63	18.99	11.50	11.04	-21.84	-12.68
Interest	2.29	2.04	0.79	0.74	0.10	2.13
Gross Profit	12.34	16.95	10.71	10.30	-21.94	-14.81
Depreciation	5.00	5.33	5.49	4.48	3.27	3.42
Profit Before Tax	7.34	11.62	5.22	5.82	-25.21	-18.23
Tax	0.00	0.28	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	1.50
Reported Net Profit	7.35	11.34	5.22	5.83	-25.20	-19.73
Extraordinary Items	0.07	0.20	-2.16	0.00	-23.33	0.00
Adjusted Net Profit	7.28	11.14	7.38	5.83	-1.87	-19.73
Adjustment below Net Profit	0.04	0.15	-0.02	0.00	0.00	0.00
P & L Balance brought forward	-54.48	-65.97	-71.17	-76.99	-51.79	-32.06
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-47.10	-54.48	-65.97	-71.17	-76.99	-51.79
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	3.11	4.79	2.21	2.46	-106.54	0.00
Earnings Per Share(Adj)-Unit Curr	3.11	4.79	2.21	2.46	-106.54	0.00
Book Value-Unit Curr	34.17	31.05	26.19	24.00	-18.64	8.79
Book Value(Adj)-Unit Curr	34.17	31.05	26.19	24.00	-18.64	8.79

24,837.00 -225.10 (-0.90%)

81,463.09 -721.08 ( -0.88%)

56,528.90 -537.15 ( -0.94%)

35,623.75 -512.05 ( -1.42%)

44,929.79 214.87 (0.48%)

6,410.96 26.61 (0.42%)

41,458.88 -367.46 (-0.88%)

9,120.31 -18.06 (-0.20%)

86.38 0.01 (0.01%)

101.61 0.16 (0.16%)

116.99 -0.03 (-0.02%)

0.59 0.00 (0.03%)